CLIN Clinigen Group Plc

TIDMCLIN

RNS Number : 8937X

Clinigen Group plc

30 November 2017

30 November 2017

Clinigen Group plc

("Clinigen" or the "Group")

Total Voting Rights and Capital

In conformity with Rule 5.6.1 of the Disclosure Guidance and Transparency Rules, the Group notifies the market that as at 30 November 2017 Clinigen's issued share capital consists of 122,268,158 ordinary shares of 0.1 pence each with voting rights. No shares are held in Treasury.

The above figure of 122,268,158 may be used by shareholders as the denominator to determine if they are required to notify their interests in, or a change to their interests in, the Group under the FCA's Disclosure Guidance and Transparency Rules.

-Ends-

Contact details

 
 Clinigen Group plc                  Tel: +44 (0) 1283 
                                      495010 
 Shaun Chilton, Group Chief 
  Executive Officer 
 Martin Abell, Group Chief 
  Financial Officer 
 Matt Parrish, Head of Investor 
  Relations 
 
 Numis Securities Limited            Tel: +44 (0) 20 
                                      7260 1000 
 Michael Meade / Freddie Barnfield 
  (Nominated Adviser) 
  James Black / Tom Ballard 
  (Corporate Broking) 
 
 RBC Capital Markets - Joint         Tel: +44 (0) 20 
  Broker                              7653 4000 
 Marcus Jackson / Elliot Thomas 
  / Jack Wood 
 
 Instinctif Partners                 Tel: +44 (0) 20 
                                      7457 2020 
 Melanie Toyne-Sewell / Alex 
  Shaw / Deborah Bell                Email: clinigen@instinctif.com 
 

About Clinigen Group

Clinigen Group plc (AIM: CLIN) is a global pharmaceutical and services company with a unique combination of businesses focused on providing ethical access to medicines. Its mission is to deliver the right medicine to the right patient at the right time through three areas of global medicine supply; clinical trial, unlicensed and licensed medicines. Clinigen acquired Quantum Pharma in November 2017.

For more information, please visit www.clinigengroup.com

This information is provided by RNS

The company news service from the London Stock Exchange

END

TVRKMMZMKLVGNZM

(END) Dow Jones Newswires

November 30, 2017 09:00 ET (14:00 GMT)

Clinigen (LSE:CLIN)
Historical Stock Chart
From Apr 2024 to May 2024

Clinigen (LSE:CLIN)
Historical Stock Chart
From May 2023 to May 2024